Literature DB >> 10521849

Prenatal diagnosis of osteogenesis imperfecta type I by COL1A1 null-allele testing.

L Nuytinck1, B S Sayli, W Karen, A De Paepe.   

Abstract

Osteogenesis imperfecta (OI) type I is caused by a reduction of type I collagen resulting from the presence of a non-functional COL1A1 allele (null-allele). Owing to the lack of mutant mRNA, genomic screening of the COL1A1 and COL1A2 genes is required to identify a causal mutation, which is a costly and time consuming endeavour. We have developed an alternative approach for confirmation of a suspected diagnosis of OI type I based on the detection of a COL1A1 null-allele. Here we report the application of this COL1A1 null-allele detection test for prenatal diagnosis in a patient with OI type I in which it was shown that the fetus had inherited the normal COL1A1 allele from his affected mother and would not be affected with OI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521849     DOI: 10.1002/(sici)1097-0223(199909)19:9<873::aid-pd645>3.0.co;2-0

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta.

Authors:  Fleur S van Dijk; Peter H Byers; Raymond Dalgleish; Fransiska Malfait; Alessandra Maugeri; Marianne Rohrbach; Sofie Symoens; Erik A Sistermans; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

2.  Femoral neck fractures in osteogenesis imperfecta treated with bisphosphonates.

Authors:  M C Papanna; S Tafazal; M J Bell; S N Giles; J A Fernandes
Journal:  J Child Orthop       Date:  2017-06-01       Impact factor: 1.548

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.